Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay.
Affiliation
CRC Department of Cancer Genetics, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Withington, Manchester, UK.Issue Date
2000-12
Metadata
Show full item recordAbstract
Of breast cancer patients, 30% are sensitive in a lymphocyte assay of radiation-induced chromosome damage (micronucleus induction) compared with 10% of healthy controls. Twenty-two first-degree relatives of 11 sensitive patients had an average micronucleus yield significantly higher than that of 68 controls. This suggests that radiosensitivity in this assay may be an inherited characteristic associated with predisposition to breast cancer.Citation
Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. 2000, 76 (12):1617-9 Int. J. Radiat. Biol.Journal
International Journal of Radiation BiologyDOI
10.1080/09553000050201109PubMed ID
11133043Type
ArticleLanguage
enISSN
0955-3002ae974a485f413a2113503eed53cd6c53
10.1080/09553000050201109
Scopus Count
Collections
Related articles
- Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy.
- Authors: Scott D
- Issue date: 2000 May
- Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
- Authors: Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D
- Issue date: 2000 May
- Cytogenetic radiosensitivity of g0-lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay.
- Authors: Mozdarani H, Mansouri Z, Haeri SA
- Issue date: 2005 Mar
- Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
- Authors: Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A
- Issue date: 2002 Dec 2
- Chromosomal radiosensitivity of triple negative breast cancer patients.
- Authors: Francies FZ, Herd O, Cairns A, Nietz S, Murdoch M, Slabbert J, Claes KBM, Vral A, Baeyens A
- Issue date: 2019 Nov